Maladie thromboembolique veineuse et cancer

[1]  H. Watzke,et al.  Use of Thromboprophylaxis in Palliative Care Patients: A Survey Among Experts in Palliative Care, Oncology, Intensive Care, and Anticoagulation , 2008, The American journal of hospice & palliative care.

[2]  M. Samama,et al.  In vitro study of the hypercoagulable state in multiple myeloma patients treated or not with thalidomide. , 2008, Thrombosis research.

[3]  F. Herrmann,et al.  Prophylactic anti-coagulation in cancer palliative care: a prospective randomised study , 2008, Supportive Care in Cancer.

[4]  A. Varki.  Trousseau's syndrome: multiple definitions and multiple mechanisms. , 2007, Blood.

[5]  A. Taher,et al.  Thalidomide and thrombosis , 2007, Thrombosis and Haemostasis.

[6]  H. Chew,et al.  Targeting patients for anticoagulant prophylaxis trials in patients with cancer: who is at highest risk? , 2007, Thrombosis research.

[7]  B. Furie,et al.  Cancer-associated thrombosis. , 2007, Critical reviews in oncology/hematology.

[8]  T. Wakefield,et al.  Risk factors associated with venous thromboembolic events in patients with malignancy , 2006, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[9]  H. Chew,et al.  Incidence of Venous Thromboembolism in the Year Before the Diagnosis of Cancer in 528, 693 Adults , 2005 .

[10]  B. Asselain,et al.  Thrombose symptomatique sur cathéter veineux central de longue durée en oncologie : un score de risque prédictif? , 2005 .

[11]  M. Prins,et al.  Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  D. Kuter.  Thrombotic complications of central venous catheters in cancer patients. , 2004, The oncologist.

[13]  A. Santoro,et al.  Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy? , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  H. Liebman,et al.  Thromboembolic complications of cancer: Epidemiology, pathogenesis, diagnosis, and treatment , 2003, American journal of hematology.

[15]  N. Pavlakis,et al.  Unexpected serious toxicity with chemotherapy and antiangiogenic combinations: time to take stock! , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  F. Carsuzaa,et al.  Thalidomide et thromboses , 2000 .

[17]  M. Levine,et al.  The Thrombophilic State Induced by Therapeutic Agents in the Cancer Patient , 1999, Seminars in thrombosis and hemostasis.

[18]  P. Prandoni,et al.  Cancer and venous thromboembolism. , 2005, American heart journal.